PhRMA

JANUARY 25, 2023

One study found, between 2000 and 2016 alone, new cancer medicines were associated with nearly 1.3 This report is the latest to document this progress. A growing body of evidence underscores the role of new medicines in recent accelerated declines in mortality across a range of cancers.

Documentation 254

Documentation 254

Pharmacy Times

SEPTEMBER 29, 2023

Investigators also found that rates of type 1 diabetes have been on the rise since 2016.

145

145

Fierce Healthcare

APRIL 3, 2024

Initially founded as an AI lab in 2016, startup Manifold is using its AI expertise to modernize the tech infrastructure of clinical research organizations to help accelerate cancer studies.

122

122

Drug Topics

FEBRUARY 14, 2023

Prevalence of IBD doubled between 1995 and 2016 and exposure to antibiotics may be to blame.

141

141

IDStewardship

DECEMBER 1, 2022

Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016; 63 (5):e61–e111. . Kalil AC, Metersky ML, Klompas M, et al. Klompas, M., Branson, R., Eichenwald, E.

Hospitals 348

Hospitals 348

STAT

MAY 2, 2024

The task force’s newest advice , which gives a “B” grade in favor of routine mammograms for women in their 40s, reverses its 2016 statement saying the test should be optional for such women. And that 2016 opinion conflicted with earlier task force recommendations.

136

136

Fierce Pharma

JUNE 20, 2023

When Sanofi made an asset swap with Boehringer Ingelheim in 2016, the French company acquired BI’s healthcare business, which included heartburn medicine Zantac. | In an asset swap with Boehringer in 2016, Sanofi gained U.S. marketing rights to the treatment.

119

119

Fierce Healthcare

MARCH 20, 2024

PocketHealth, founded in 2016 by Rishi and his brother Harsh, gives patients instant access to their medical images from partner providers and enables image exchange between providers. PocketHealth, a medical image exchange platform, has raised $33 million in a series B round.

121

121

Pharmacy Times

JULY 17, 2023

FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.

FDA 123

FDA 123

Pharmacy Times

NOVEMBER 11, 2022

Updated prescribing guidelines issued in 2014 and 2016 may explain lower use of opioids by 11.7% among patients with chronic, nonsurgical pain.

123

123

STAT

JUNE 13, 2024

With some of the highest obesity levels in South America, the country had begun enforcing strict regulations on Frosted Flakes and other foods that exceeded set thresholds for sugar, calories, salt, or saturated fat in 2016. Read the rest…

128

128

STAT

FEBRUARY 6, 2024

In the eight years between the drug’s spectacular 2016 debut on the cover of Nature and its ignominious end , Biogen made multiple, really bad decisions. Its decision, the company explained, is not a response to new data about the drug’s safety or efficacy, but instead “a reprioritization of resources.”

FDA 145

FDA 145

STAT

OCTOBER 10, 2022

I first met Wes Ely in 2016, when I wrote about ICU delirium and Ely’s attempts, as a critical-care physician at Vanderbilt University Medical Center, to urge fellow health care workers to rethink the use of heavy sedation in ICUs. Well, a lot’s happened since 2016.

Hospitals 123

Hospitals 123

STAT

OCTOBER 31, 2024

In 2016, a number of states filed what eventually became the first in a trio of lawsuits against many of the largest generic companies for allegedly coordinating efforts to fix and maintain prices for dozens of medications to treat a variety of ailments.

132

132

STAT

JULY 16, 2024

The data, gathered in 2022, is part of the agency’s Disability and Health Data System , which has annual state and national-level data stretching back to 2016. This comorbidity looms large for many disabled communities as another surge in Covid cases sweeps the country.

145

145

STAT

DECEMBER 27, 2023

Philips Respironics, a subsidiary of Philips, allegedly gave out masks from 2016 to 2021. The masks, according to a press release from the Department of Justice, were used to diagnose and treat sleep disorders. The case never went to court. The DOJ says Philips violated the Anti-Kickback Statute as well as the False Claims Act.

136

136

STAT

JULY 22, 2024

The report , which was released in March but received little if any public attention, examined drug spending between 2016 and 2021 within the health plan that covers more than 200,000 unionized mail carriers and post office workers, as well as retirees.

Pharmaceutical Companies 145

Pharmaceutical Companies Pharmaceutical Companies 145

STAT

OCTOBER 18, 2023

It joins the original San Francisco Biohub founded in 2016 and a Chicago Biohub founded earlier this year. Read the rest…

145

145

Fierce Pharma

OCTOBER 18, 2023

The accusations centered on the company's compensation of 86 female employees in 2015 and 2016. Department of Labor that it underpaid certain women who were employed at the company’s New York City headquarters. |

126

126

STAT

SEPTEMBER 19, 2023

WASHINGTON — Rep. Adam Smith (D-Wash.) knew when he hit rock bottom.

133

133

STAT

NOVEMBER 20, 2024

In 2016, the Arkansas Legal Aid Center was flooded with calls. People on a Medicaid program that provided in-home care assistance were having their caregiving hours cut. Reducing the hours for somebody with quadriplegia or cerebral palsy was devastating, said Kevin De Liban, an attorney with the organization at the time.

135

135

STAT

JUNE 10, 2024

Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022.   In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020.   The issue isn’t new.

FDA 139

FDA 139

IDStewardship

APRIL 16, 2023

In 2016 a pharmacy professor developed a blog post about five reasons why people fail the NAPLEX. Curious to read the article about why people fail the NAPLEX from 2016? Now years later, he revisits the topic here. Authored By: Christopher Bland, Pharm.D., If you do, refocus and you can pass on the next attempt!

Compounding 245

Compounding 245

Fierce Pharma

SEPTEMBER 11, 2024

The regulator specifically raised an eyebrow at the post-marketing trials Intercept has used in a bid to keep hold of the accelerated approval it won back in 2016.

FDA 111

FDA Documentation 111

STAT

JANUARY 10, 2024

This latest revision, known as the DSM-5-TR, was prepared between 2016 and 2019, and published in 2022. -based physicians who helped assemble a recent revision of the Diagnostic and Statistical Manual of Mental Disorders, which is often referred to as the bible of psychiatry.

Pharmaceutical Companies 145

Pharmaceutical Companies Pharmaceutical Companies 145

STAT

FEBRUARY 13, 2024

They’re investing in insurance brokerages, marketers, in-home assessment companies, and “insurtechs,” the report said, based on a new analysis of deals in the space since 2016.

Insurance 132

Insurance 132

STAT

FEBRUARY 2, 2023

Read the rest…

133

133

Fierce Pharma

SEPTEMBER 16, 2024

Looking to assess whether Ocaliva met its postmarketing requirements after a 2016 accelerated approval in the autoimmune disease primary biliary cholangitis, an FDA council of outside experts nearly unanimously rejected Intercept’s hopes for a full approval.

FDA 105

FDA 105

STAT

APRIL 5, 2024

The company earned its first clearance from the Food and Drug Administration in 2016 , and went public in 2019 at a share price of $17.  According to a press statement, Shockwave has treated 400,000 patients with this method globally.

142

142

STAT

APRIL 19, 2024

They examined data spanning January 2016 through June 2021 at 619 U.S. “There is an urgent need to understand why clinicians at hospitals with access to newer agents do not always prefer newer agents,” the researchers wrote in the Annals of Internal Medicine. Continue to STAT+ to read the full story…

Hospitals 139

Hospitals 139

STAT

SEPTEMBER 5, 2023

The appointment follows a bitter board fight that ended with the departure of Francis deSouza, who had been Illumina’s CEO since 2016. Illumina, the largest maker of DNA-sequencing technology and a storied name in the biotechnology industry, named Jacob Thaysen, a 10-year-veteran at life sciences-tools firm Agilent, as its new CEO.

137

137

STAT

JANUARY 18, 2024

In 2016, the 21 st Century Cures Act required that the U.S. make progress toward interoperability, which it defined as “all electronically accessible health information” to be accessed, exchanged and used “without special effort on the part of the user.”

107

107

STAT

OCTOBER 18, 2024

billion in 2016. Since it began more than 30 years ago, the program has ballooned and fed into the national clash over the cost of medicines. Some $38 billion in prescription medications were purchased under the 340B program in 2020, for instance, which was up from $16.2 Continue to STAT+ to read the full story…

Hospitals 133

Hospitals 133

Fierce Pharma

JUNE 8, 2023

Novartis’ generics and biosimilars unit Sandoz—soon to be spun off as a stand-alone company—has seen a decline | Novartis’ generics and biosimilars unit Sandoz—soon to be spun off as a stand-alone company—has seen a decline in revenue every year since 2016.

117

117

STAT

SEPTEMBER 21, 2023

Intarcia started developing its lead therapy, a small, skinny bar implanted under the skin, for type 2 diabetes patients in 2016. The agency is not bound to advisory panel decisions, though it tends to follow their advice.

FDA 141

FDA 141

STAT

DECEMBER 11, 2023

After his death in 2016, his mother, Paula, launched a campaign to mandate training on intellectual disability and autism for health care workers. A few days later, Oliver suffered a lethal neurological side effect. A week later, he was taken off life support. An inquest into his death found that the drug had led to the rapid deterioration.

Medical Schools 144

Medical Schools Communication Hospitals 144

Pharmaceutical Technology

DECEMBER 19, 2023

Sanofi and Innate’s cancer collaboration agreement stretches back to 2016, with two of Sanofi’s NK cell engagers in clinical studies.

98

98